Oncocare Medicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 02-01-2025
- Paid Up Capital ₹ 5.00 M
as on 02-01-2025
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.85 Cr
as on 02-01-2025
- Satisfied Charges ₹ 3.76 Cr
as on 02-01-2025
- Revenue 2.50%
(FY 2022)
- Profit 23.65%
(FY 2022)
- Ebitda 2.22%
(FY 2022)
- Net Worth 36.34%
(FY 2022)
- Total Assets 29.39%
(FY 2022)
About Oncocare Medicals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹17.85 Cr. The company has closed loans amounting to ₹3.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
Richa Agarwal, Ajay Agarwal, and Rajesh Agarwal serve as directors at the Company.
- CIN/LLPIN
U74900UP2011PTC044358
- Company No.
044358
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Apr 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Oncocare Medicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Richa Agarwal  | Director | 13-Apr-2011 | Current |
| Ajay Agarwal | Director | 13-Apr-2011 | Current |
| Rajesh Agarwal | Director | 13-Apr-2011 | Current |
Financial Performance of Oncocare Medicals.
Oncocare Medicals Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.5% increase. The company also saw a substantial improvement in profitability, with a 23.65% increase in profit. The company's net worth Soared by an impressive increase of 36.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oncocare Medicals?
In 2022, Oncocare Medicals had a promoter holding of 60.00% and a public holding of 40.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ran Bienes Raices LlpActive 2 years 2 monthsRicha Agarwal, Ajay Agarwal and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 31 Jul 2018 | ₹3.00 Cr | Open |
Hdfc Bank Limited Creation Date: 28 Apr 2017 | ₹14.85 Cr | Open |
Punjab National Bank Creation Date: 16 Mar 2015 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Oncocare Medicals?
Oncocare Medicals has a workforce of 38 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oncocare Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oncocare Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
